Jun 21 |
With 60% ownership of the shares, OmniAb, Inc. (NASDAQ:OABI) is heavily dominated by institutional owners
|
Jun 3 |
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
|
May 31 |
Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 34%?
|
May 12 |
OmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call Transcript
|
May 11 |
We're Keeping An Eye On OmniAb's (NASDAQ:OABI) Cash Burn Rate
|
May 11 |
OmniAb First Quarter 2024 Earnings: Misses Expectations
|
May 10 |
OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript
|
May 9 |
OmniAb, Inc. 2024 Q1 - Results - Earnings Call Presentation
|
May 9 |
OmniAb GAAP EPS of -$0.19 misses by $0.03, revenue of $3.8M misses by $2.07M
|
May 9 |
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
|